Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Amortization of Deferred Charges (2019 - 2025)

Catheter Precision (VTAK) has disclosed Amortization of Deferred Charges for 3 consecutive years, with $17000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Amortization of Deferred Charges changed N/A to $17000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $193000.0, a 26.05% decrease, with the full-year FY2019 number at $330000.0, changed N/A from a year prior.
  • Amortization of Deferred Charges was $17000.0 for Q3 2025 at Catheter Precision, down from $76000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $17000.0 in Q3 2025 to a low of $17000.0 in Q3 2025.